3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
34
Ovarian Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Neoplasms
3
Hereditary Sensory and Autonomic Neuropathies
3
Prostatic Neoplasms
2
Neoplasms by Site
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Diseases
2
Advanced Solid Tumors
2
Triple Negative Breast Neoplasms
1
Spinocerebellar Degenerations
1
Solid Tumor, Adult
1
Neoplasm Metastasis
1
Melanoma
1
HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
1
HR+/HER2- Breast Cancer
1
HER2-positive Metastatic Breast Cancer
1
HER2-positive Breast Cancer
1
Fallopian Tube Neoplasms
1
Estrogen Receptor Positive Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Ductal, Breast
1
Brain Neoplasms
1
Interventions
capivasertib
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Estrogen Receptor Positive Breast Cancer
×
Fulvestrant
×
Clear all
NCT01992952
2025-11-26
FAKTION
Velindre NHS Trust
Phase 1/2
Active not recruiting
149 enrolled